Does the current climax of economy spells nothing but downhill for Biomedical Science (BMS) industry?
Hopes can be set high with key announcements made by leading pharmaceutical companies in Feburary 2009:

Abbott opened its largest nutrition manufacturing facility and announced its extension into nutrition R&D in Singapore;
Schering-Plough opened its Translation Medicine Research Centre;
Lilly announced its collaboration [...]

In 2009, we will see the opening of Schering-Plough Translational Medicine Research Centre (TMRC) in Singapore. The TMRC is a branch of the Schering-Plough Research Institute (SPRI) and it will consist of 2 planned components:

Translational Research Lab (TRL) – scheduled to open in February, 2009

Translational Medicine Unit (TMU) – will run about 20-30 clinical [...]

What happen when a novel discovery has been made? What happen when an ingenious theory has been proposed?
Enormous amount of research can be done in laboratories each day. But, do they continue to stay on top of laboratory benches, in the brilliant minds, or simply go unnoticed? What does it mean to the public at [...]

Every great discovery needs to be attached with a value – value for the society, for the greater good. This is exactly what Dyamed did.

The year marks a good start for research commercialization (translation research), as Dyamed licenses Lab-in-a-Catridge, “MicroKit”, from the Institute of Bioengineering and Nanotechnology (IBN), on January 16 2009 (Media release). With [...]

What is it?
“Translational research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications…” – definition from Translational Research Working Group (TRWG) .
Discoveries generally kick off as basic research on the “bench”, but it is important to translate these marvelous progresses to the patient’s “bedside”, on a clinical level. Thus, as rightfully [...]